Nanoform, an innovative nanoparticle medicine enabling company, has established Nanoform USA Inc., a wholly owned subsidiary in the US. This is a natural progression for the company as it continues to increase the impact of its award-winning nanonization™ technology and expand its major pharma client base in the US.
Prof. Edward Hæggström, Nanoform CEO, commented: “We are tremendously excited to have officially established our presence in the US with a wholly owned subsidiary. This comes as a natural next step for our company as we continue to expand the reach of our nanonization™ technology.”
Miguel Calado, Vice Chairman of the Nanoform Board, said, “I am thrilled we are establishing Nanoform USA Inc. With this strategic expansion, we now have a strong foundation on which to continue to grow our presence in the US.”
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to reduce clinical attrition and enhance their molecules formulation performance through its best-in-class nanonization™ services.
For more information please visit https://nanoform.com/